Varenicline Adjunctive Treatment in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

April 30, 2011

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Interventions
DRUG

Varenicline

Varenicline 0.5mg po qd x 7 days then titrated to Varenicline 0.5mg po bid x 7 weeks

DRUG

Placebo

Placebo 0.5mg po qd x 7 days then titrated to Placebo 0.5mg po bid x 7 weeks

Trial Locations (3)

21201

UMB School of Medicine, Baltimore

University of Maryland Medical System, Baltimore

21228

Maryland Psychiatric Research Center, Baltimore

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00492349 - Varenicline Adjunctive Treatment in Schizophrenia | Biotech Hunter | Biotech Hunter